BiotechTube
Vivasure Medical

Vivasure Medical

Galway, Ireland· Est.
vivasuremedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $80M

Overview

Vivasure Medical is a pioneer in large-bore vascular closure, having developed the PerQseal® Elite, the first and only 100% bio-absorbable, sutureless patch-based system designed for arterial and venous access. The company, based in Galway, Ireland, operates a fully integrated R&D and manufacturing facility and has achieved CE Mark approval for its flagship product. Its acquisition by Haemonetics in early 2026 provides significant commercial and operational backing to scale its technology in global markets, particularly for structural heart and complex endovascular procedures.

Cardiovascular

Technology Platform

PerQseal® Technology: A platform for 100% bio-absorbable, synthetic polymer, sutureless patch-based closure systems for percutaneous large-bore arterial and venous access site management.

Funding History

3
Total raised:$80M
Series C$40M
Series B$30M
Series A$10M

Opportunities

The rapid growth of minimally invasive structural heart and complex endovascular procedures creates a large and expanding addressable market for purpose-built large-bore closure devices.
The acquisition by Haemonetics provides a global commercial platform and financial resources to accelerate market penetration and support regulatory pathways, particularly in the United States.

Risk Factors

Key risks include the uncertainty and cost associated with obtaining FDA approval for the US market, the challenge of commercial execution and integration post-acquisition, and intensifying competition from both established medtech companies and new entrants in the vascular closure space.

Competitive Landscape

The competitive landscape includes traditional suture-based closure devices (e.g., ProGlide from Abbott) and plug-based devices often used off-label for large bore sites, as well as emerging dedicated large-bore devices from other companies. Vivasure's primary competitive advantage is its fully bio-absorbable, sutureless patch technology designed specifically for this indication.

More companies in Drug Delivery & Formulation →More companies in Ireland →